Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
IRWD
$3.64
-3.19%
IRWD
· Ironwood Pharmaceuticals Inc
$3.64
-0.12 (-3.19%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$682.44M
Shares
165.24M
Volume · Oct 2
2.7M
Avg daily vol (3M)
2.12M
All webcasts
Earnings call · FY2026 Q2
Ironwood Pharmaceuticals Inc (IRWD) Q2 2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$113.04M
+32.6% YoY
Diluted EPS
$0.31
+121.4% YoY
Net income
$51.29M
+117.3% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Adjusted EBITDA
2026
|
at least $310M | Non-GAAP |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document